Search Results ""
Results from Vall d´Hebron´s High Risk and Cancer Prevention Unit (UARPC) recently presented at the European Society of Medical Oncology (ESMO) Congress 2012 (Vienna, 28 September – 02 October) show that the high percentage of premalignant lesions detected in different organs in these adolescents and young people not only justifies these programmes but makes them indispensable.
• The team will be coordinating a study that aims to investigate whether the BKM120 drug can be regarded as…
Nature Medicine´s Senior Editor, Victoria Aranda, will come to VHIO Monday 17 September 2012 to deliver the 4th in the…
New Herceptin® delivery method could vastly simplify breast cancer treatment A new method of delivering a commonly used breast cancer…
In two recent interviews with ecancer Josep Tabernero highlights key studies and promising data presented at the ESMO 14th World Congress on Gastrointestinal Cancer (WCGC), Barcelona, 27 – 30 June 2012, as well as discusses the WIN Consortium (Worldwide Innovative Networking in personalized cancer medicine) launch of WINTHER: The WIN therapeutics clinical trial.
On 12 July 2012, internationally renowned experts in renal carcinoma, Dr. Brian Rini and Dr. Jorge García from the Cleveland…
